The use of prescription opioids is a matter of concern among academics and practitioners, but there remains a lack of programming to target this issue. One program, This Is (Not) About Drugs (TINAD), is intended to address part of this need by altering youth perceptions of the risks associated prescription opioid misuse as well as heroin. This study presents results from a quasi-experimental evaluation of TINAD. Propensity score matching techniques were used to account for selection effects across treatment and comparison groups. Program participants demonstrated increases in understanding of the similarities between prescription opioids and heroin and the risks associated with prescription opioid misuse. While these results are promising, TINAD requires a more rigorous evaluation of its effectiveness.
AbadieA.ImbensG. W. (2016). Matching on the estimated propensity score. Econometrica, 84(2), 781–807. https://doi.org/10.3982/ECTA11293
2.
AliB.FisherD. A.MillerT. R.LawrenceB. A.SpicerR. S.SwedlerD. I.AllisonJ. (2019). Trends in drug poisoning deaths among adolescents and young adults in the United States, 2006-2015. Journal of Studies on Alcohol and Drugs, 80(2), 201–210. https://doi.org/10.15288/jsad.2019.80.201
3.
BaborT. F.McReeB. G.KassebaumP. A.GrimaldiP. L.AhmendK.BrayJ. (2007). Screening, brief intervention, and referral to treatment (SBIRT): Toward a public health approach to the management of substance abuse. Substance Abuse, 28(3), 7–30. https://doi.org/10.1300/J465v28n03_03
BeetsM. W.FlayB. R.VuchinichS.SnyderF. J.AcockA.Kin-KItL.BurnsK.WashburnI. J.DurlakJ. (2009). Use of a social and character development program to prevent substance use, violent behaviors, and sexual activity among elementary-school students in Hawaii. American Journal of Public Health, 99(8), 1438–1445. https://doi.org/10.2105/AJPH.2008.142919
6.
BotvinG. J.GriffinK. W.DiazT.ScheierL. M.WilliamsC.EpsteinJ. (2000). Preventing illicit drug use in adolescents: Long-term follow-up data from a randomized control trial of a school population. Addictive Behaviors, 25(5), 769–774. https://doi.org/10.1016/S0306-4603(99)00050-7
BoydC. J.McCabeS. E.TeterC. (2006b). Medical and nonmedical use of prescription pain medication by youth in a detroit-area public school district. Drug and Alcohol Dependence, 81(1), 37–45. https://doi.org/10.1016/j.drugalcdep.2005.05.017
9.
CarsonD. (2019). Quasi-experimental evaluation of TINAD overdose lifeline this is Not about drugs program. Indiana University Public Policy Institute.
10.
CheeksJ. M.BriggsS. R. (2013). Aspects of identity questionnaire (AIQ-IV): Measurement Instrument Database for the Social Science.
11.
ComptonW. M.JonesC. M.BaldwinG. T.HardingF. M.BlancoC.WargoE. M. (2019). Targeting youth to prevent later substance use disorder: An underutilized response to the US opioid crisis.American Journal of Public Health, 109(S3), S185–SS89. https://doi.org/10.2105/AJPH.2019.305020
CrowleyD. M.JonesD. E.CoffmanD. L.GreenbergM. T. (2014). Can we build an efficient response to the prescription drug abuse epidemic? Assessing the cost effectiveness of universal prevention in the PROSPER trial. Preventative Medicine, 62, 71–77. https://doi.org/10.1016/j.ypmed.2014.01.029
14.
DuRantR. H.SmithJ. A.KreiterS. R.KrowchukD. P. (1999). The relationship between early age of onset of initial substance use and sexual risk-taking behavior. Archives of Pediatrics and Adolescent Medicine, 153(3), 250–255. https://doi.org/10.1001/archpedi.153.3.286
15.
EsbensenF.-A.PetersonD.TaylorT. J.FrengA. (2010). Youth violence: Sex and race differences in offending, victimization, and gang membership. Temple University Press.
16.
GaitherJ. R.LeventhalJ. M.RyanS. A.CamengaD. R. (2016). National trends in hospitalizations for opioid poisonings among children and adolescents, 1997-2012. JAMA Pediatrics, 170(12), 195–1201. https://doi.org/10.1001/jamapediatrics.2016.2154
17.
GreenwoodP. W. (2006). Changing lives: Delinquency prevention as crime-control policy. University of Chicago Press.
18.
GreenwoodP. W.WelshB. C. (2012). Promoting evidence-based practice in delinquency prevention at the state level: Principles, progress, and policy direction. Criminology & Public Policy, 11(3), 493–513. https://doi.org/10.1111/j.1745-9133.2012.00826.x
19.
GuyG. P.ZhangK.BohmM. K.LosbyJ.LewisB.YoungR.MurphyL. B.DowellD. (2017). Vital signs: Changes in opioid prescribing in the United States, 2006-2015. Morbidity and Mortality Weekly Report, 66(26), 697–704. https://doi.org/10.15585/mmwr.mm6626a4
20.
HairJ.JosephF.BlackW. C.BabinB. J.AndersonR. E. (2009). Multivariate data analysis. Prentice Hall.
21.
HandleyM. A.LylesC. R.McCullochC.CattamanchiA. (2018). Selecting and improving quasi-experimental designs in effectiveness and implementation research. Annual Review of Public Health, 39(1), 5–25. https://doi.org/10.1146/annurev-publhealth-040617-014128
HudginsJ. D.PorterJ. J.MonuteauxM. C.BourgeoisF. T. (2019). Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study. PLoS Medicine, 16(11), e1002922. https://doi.org/10.1371/journal.pmed.1002922
24.
HuizingaD.EsbensenF.-A.WeiherA. W. (1991). Are there multiple paths to delinquency?Journal of Criminal Law and Criminology, 82(1), 83–118. https://doi.org/10.2307/1143790
25.
KeyesK. M.CerdaM.BradyJ. E.HavensJ. R.GaleaS. (2014). Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. American Journal of Public Health, 104(2), e52–e59. https://doi.org/10.2105/AJPH.2013.301709
26.
LankenauS.TetiM.SilvaK.BloomJ. J.HarocoposA.TreeseM. (2012). Initiation into prescription opioid misuse amongst young injection drug users. International Journal of Drug Policy, 23(1), 37–44. https://doi.org/10.1016/j.drugpo.2011.05.014
27.
LeuvenE.SianesiB. (2003). PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing.
28.
LewisK. M.BavarianN.SnyderF. J.AcockA.DayJ.DuBoisD. L.JiP.SchureM. B.SilverthornN.VuchinichS.FlayB. R. (2012). Direct and mediated effects of a social-emotional and character development program on adolescent substance use. International Journal of Emotional Education, 4(1), 46–78.
29.
McCabeS. E. (2011). Medical misuse of controlled medications among adolescents. Archives of Pediatrics and Adolescent Medicine, 165(8), 739. https://doi.org/10.1001/archpediatrics.2011.114
30.
MiechR.JohnstonL. D.O'MalleyP. M.KeyesK. M.HeardK. (2015). Prescription opioids in adolescence and future opioid misuse. Pediatrics, 136(5), e1169–e1177. https://doi.org/10.1542/peds.2015-1364
31.
National Institute on Drug Abuse (NIDA): Misuse of Prescription Drugs (2018). https://www.drugabuse.gov/node/pdf/2609/misuse-of-prescription-drugs.
32.
SpothR.ClairS.ShinC.RedmondC. (2006). Long-term effects of universal preventive interventions on methamphetamine use among adolescents. Archives of Pediatrics and Adolescent Medicine, 160(9), 876–882. https://doi.org/10.1001/archpedi.160.9.876
33.
SpothR.RedmondC.ChinC.AzevedoK. (2004). Brief family intervention effects on adolescent substance initiation: School-level growth curve analyses 6 years following baseline. Journal of Consulting and Clinical Psychology, 72(3), 535–542. https://doi.org/10.1037/0022-006X.72.3.535
34.
SpothR.RedmondC.ShinC.GreenbergM.ClairS.FeinbergM. (2007). Substance-use outcomes at 18 months past baseline: The PROSPER community-university partnership trial. American Journal of Preventive Medicine, 32(5), 395–402. https://doi.org/10.1016/j.amepre.2007.01.014
35.
SpothR.TrudeauL.ShinC.RalstonE.RedmondC.GreenbergM.FeinbergM. (2013). Longitudinal effects of universal preventive intervention on prescription drug misuse: Three randomized controlled trials with late adolescents and young adults. American Journal of Public Health, 103(4), 665–672. https://doi.org/10.2105/AJPH.2012.301209
36.
SpothR.TrudeauL.ShinC.RedmondC. (2008). Long-term effects of universal preventive interventions on prescription drug misuse. Addiction, 103(7), 1160–1168. https://doi.org/10.1111/j.1360-0443.2008.02160.x
37.
SussmanS.PentzM. A.Spruijt-MetzD.MillerT. (2006). Misuse of "study drugs:" Prevalence, consequences, and implications for policy. Substance Abuse Treatment, Prevention, and Policy, 1(15), 1–7. https://doi.org/10.1186/1747-597X-1-15
38.
TapertS. F.AaronsG. A.SedlerG. R.BrownS. A. (2001). Adolescent substance use and sexual risk-taking behavior. Journal of Adolescent Health, 28(3), 181–189. https://doi.org/10.1016/S1054-139X(00)00169-5
TwomblyE. C.HoltzK. D. (2008). Teens and the misuse of prescription drugs: Evidence-based recommendations to curb a growing societal problem. Journal of Primary Prevention, 29(6), 503–516. https://doi.org/10.1007/s10935-008-0157-5
41.
TwomblyE. C.HoltzK. D.AgnewC. B. (2011). Resonant messages to prevent prescription drug misuse by teens. Journal of Alcohol and Drug Education, 55(1), 38–52.
42.
WarnerM.ChenL. H.MakucD. M.AndersonR. N.MininoA. M. (2011). Drug poisoning deaths in the United States, 1980-2008. (NCHS Data Brief no. 81). National Center for Health Statistics.
43.
WilsonN.KariisaM.SethP.SmithH.DavisN. L. (2020). Drug and opioid-involved overdose deaths — United States, 2017–2018. Morbidity and Mortality Weekly Report, 69(11), 290–297.
